Oak Harbor Wealth Partners’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.88M Buy
66,986
+1,960
+3% +$52.2K 0.44% 61
2025
Q4
$1.62M Buy
65,026
+650
+1% +$16.4K 0.39% 64
2025
Q3
$1.64M Sell
64,376
-1,738
-3% -$42.9K 0.41% 58
2025
Q2
$1.6M Sell
66,114
-728
-1% -$17K 0.43% 57
2025
Q1
$1.69M Buy
66,842
+1,050
+2% +$27.5K 0.48% 51
2024
Q4
$1.75M Sell
65,792
-8,036
-11% -$218K 0.51% 51
2024
Q3
$2.14M Buy
73,828
+2,375
+3% +$69.3K 0.61% 43
2024
Q2
$2M Buy
71,453
+549
+0.8% +$15.1K 0.63% 43
2024
Q1
$1.97M Buy
70,904
+11
+0% +$305 0.61% 46
2023
Q4
$2.04M Buy
70,893
+1,306
+2% +$39.5K 0.69% 42
2023
Q3
$2.31M Sell
69,587
-1,292
-2% -$45.7K 0.82% 34
2023
Q2
$2.6M Buy
70,879
+2
+0% +$78 0.89% 32
2023
Q1
$2.89M Buy
70,877
+404
+0.6% +$17.4K 1.05% 26
2022
Q4
$3.61M Buy
70,473
+102
+0.1% +$4.89K 1.38% 21
2022
Q3
$3.08M Buy
70,371
+204
+0.3% +$9.91K 1.21% 22
2022
Q2
$3.68M Sell
70,167
-297
-0.4% -$15.1K 1.47% 19
2022
Q1
$3.65M Buy
70,464
+203
+0.3% +$10.5K 1.2% 24
2021
Q4
$4.15M Buy
+70,261
New +$3.48M 1.43% 17

Other funds holding PFE

Oak Harbor Wealth Partners's PFE Position: Q1 2026 in Review

Oak Harbor Wealth Partners increased its Pfizer (PFE) stake by 3% in Q1 2026, buying an estimated $52.2K and bringing the position to 66,986 shares worth $1.88M. The position accounts for 0.44% of the portfolio, ranked #61.

Oak Harbor Wealth Partners first reported a position in PFE in Q4 2021 and has held it in 18 quarters since. The position peaked at $4.15M in Q4 2021. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Oak Harbor Wealth Partners held 66,986 shares of Pfizer worth $1.88M as of Q1 2026.
  • Oak Harbor Wealth Partners bought 1,960 Pfizer shares in Q1 2026, an estimated $52.2K.
  • Pfizer made up 0.44% of Oak Harbor Wealth Partners's portfolio in Q1 2026, its #61 holding.
  • Oak Harbor Wealth Partners first reported a position in Pfizer in Q4 2021 and has held it in 18 quarters since.
  • Oak Harbor Wealth Partners's Pfizer position peaked at $4.15M in Q4 2021.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Oak Harbor Wealth Partners's 13F filing for Q1 2026, filed 7 May 2026.